BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16272201)

  • 1. Increased natriuretic peptide receptor A and C gene expression in rats with pressure-overload cardiac hypertrophy.
    Christoffersen TE; Aplin M; Strom CC; Sheikh SP; Skott O; Busk PK; Haunso S; Nielsen LB
    Am J Physiol Heart Circ Physiol; 2006 Apr; 290(4):H1635-41. PubMed ID: 16272201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac gene expression of natriuretic substances is altered in streptozotocin-induced diabetes during angiotensin II-induced pressure overload.
    Ruzicska E; Foldes G; Lako-Futo Z; Sarman B; Wellmann J; Szenasi G; Tulassay Z; Ruskoaho H; Toth M; Somogyi A
    J Hypertens; 2004 Jun; 22(6):1191-200. PubMed ID: 15167455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart.
    Dickey DM; Flora DR; Bryan PM; Xu X; Chen Y; Potter LR
    Endocrinology; 2007 Jul; 148(7):3518-22. PubMed ID: 17412809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-II down-regulates cardiac natriuretic peptide receptor-A mediated anti-hypertrophic signaling in experimental rat hearts.
    Gopi V; Parthasarathy A; Umadevi S; Vellaichamy E
    Indian J Exp Biol; 2013 Jan; 51(1):48-55. PubMed ID: 23441479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II down-regulates natriuretic peptide receptor-A expression and guanylyl cyclase activity in H9c2 (2-1) cardiac myoblast cells: Role of ROS and NF-κB.
    Gopi V; Subramanian V; Manivasagam S; Vellaichamy E
    Mol Cell Biochem; 2015 Nov; 409(1-2):67-79. PubMed ID: 26215453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide receptors in hypertrophied adult rat cardiomyocytes.
    Nader L; Lahoud L; Chouery E; Aftimos G; Bois P; Farès NA
    Ann Cardiol Angeiol (Paris); 2010 Feb; 59(1):20-4. PubMed ID: 19969282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gestational hypertension in atrial natriuretic peptide knockout mice and the developmental origins of salt-sensitivity and cardiac hypertrophy.
    Armstrong DW; Tse MY; O'Tierney-Ginn PF; Wong PG; Ventura NM; Janzen-Pang JJ; Matangi MF; Johri AM; Croy BA; Adams MA; Pang SC
    Regul Pept; 2013 Sep; 186():108-15. PubMed ID: 23981445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat.
    Brown LA; Nunez DJ; Wilkins MR
    J Clin Invest; 1993 Dec; 92(6):2702-12. PubMed ID: 7902846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
    Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis.
    Ellmers LJ; Knowles JW; Kim HS; Smithies O; Maeda N; Cameron VA
    Am J Physiol Heart Circ Physiol; 2002 Aug; 283(2):H707-14. PubMed ID: 12124219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial secretion of ANP is suppressed in renovascular hypertension: shifting of ANP secretion from atria to the left ventricle.
    Tan R; Ahn YM; Kim HY; Lee YJ; Cho KW; Kang DG; Lee HS
    Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H590-H601. PubMed ID: 29979625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of endocardial natriuretic peptide receptors in right ventricular hypertrophy.
    Kim SZ; Cho KW; Kim SH
    Am J Physiol; 1999 Dec; 277(6):H2280-9. PubMed ID: 10600847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.
    Crook RB; Chang AT
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):49-55. PubMed ID: 9164840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal hyporesponsiveness to atrial natriuretic peptide in congestive heart failure results from reduced atrial natriuretic peptide receptor concentrations.
    Bryan PM; Xu X; Dickey DM; Chen Y; Potter LR
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1636-44. PubMed ID: 17264312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats.
    Magga J; Kalliovalkama J; Romppanen H; Vuolteenaho O; Pörsti I; Kähönen M; Tolvanen JP; Ruskoaho H
    J Hypertens; 1999 Nov; 17(11):1543-52. PubMed ID: 10608466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload.
    Patel JB; Valencik ML; Pritchett AM; Burnett JC; McDonald JA; Redfield MM
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H777-84. PubMed ID: 15778276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide: a myocyte-specific marker for characterizing load-induced alterations in cardiac gene expression.
    Magga J; Vuolteenaho O; Tokola H; Marttila M; Ruskoaho H
    Ann Med; 1998 Aug; 30 Suppl 1():39-45. PubMed ID: 9800882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients.
    Dessì-Fulgheri P; Sarzani R; Tamburrini P; Moraca A; Espinosa E; Cola G; Giantomassi L; Rappelli A
    J Hypertens; 1997 Dec; 15(12 Pt 2):1695-9. PubMed ID: 9488224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N(G)-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism.
    Suo M; Kalliovalkama J; Pörsti I; Jolma P; Tolvanen JP; Vuolteenaho O; Ruskoaho H
    J Cardiovasc Pharmacol; 2002 Sep; 40(3):478-86. PubMed ID: 12198334
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.